Read more about the article A clinical study of 40 women taking tamoxifen starts in April. Recruitment starts now.
Clinical Trials Word Cloud on White Background

A clinical study of 40 women taking tamoxifen starts in April. Recruitment starts now.

This is a collaboration between Karolinska Institutet/hospital, ScientificMed AB and redhot diagnostics AB  In this joint venture, 40 women that are prescribed tamoxifen will be monitored for four weeks.  Blood samples…

Continue ReadingA clinical study of 40 women taking tamoxifen starts in April. Recruitment starts now.

Preliminary results using the rhelise kit to measure tamoxifen and metabolite concentrations in blood

Preliminary Results Using a Kit to Measure Tamoxifen and Metabolites Concentrations in Capillary Blood Samples from Women with Breast Cancer In a joint venture between Karolinska Institutet and redhot diagnostics…

Continue ReadingPreliminary results using the rhelise kit to measure tamoxifen and metabolite concentrations in blood

redhot diagnostics receives an Intention to Grant from the European Patent Office for the rhelise™ kit. Application no. PCT/EP2020/051233

redhot diagnostics AB (redhot) 20 July 2021 has received an Intention to Grant notice from the European Patent Office (“EPO”) for its patent application for the rhelise™ kit. The rhelise™…

Continue Readingredhot diagnostics receives an Intention to Grant from the European Patent Office for the rhelise™ kit. Application no. PCT/EP2020/051233